Table 1 Significant novel loci associated with SHS with a lead variant at least 500 kb from any of the previously published genome-wide significant sleep variants

From: Genome-wide association analysis of composite sleep health scores in 413,904 individuals

SHS

Loc.

SNP

Chr.

Position (GRCh37)

Nearest gene(s)

Alleles (E/A)

EAF

INFO

BETA

SE

P

ADD

1

rs75607302

4

159677732

PPID/FNIP2

A/AT

0.428

0.977

−0.013

0.002

2.8E − 09

 

2

rs10808575

8

130062388

AC068570.1/LINC00977

T/C

0.733

0.997

0.014

0.002

2.8E − 09

 

3

rs12257317

10

19457469

UBE2V2P1/MALRD1

A/G

0.685

0.997

0.013

0.002

5.7E − 09

 

4

rs7924036

10

65191645

JMJD1C

G/T

0.497

1.000

−0.012

0.002

7.4E − 09

 

5

rs72896891

18

42632654

SETBP1

A/T

0.833

0.993

−0.018

0.003

6.8E − 10

PC1

6

rs12759956

1

18432831

RP11-174G17.2/IGSF21

T/A

0.713

0.995

0.017

0.003

4.0E − 10

 

7

rs12470733

2

200968215

C2orf47/SPATS2L

C/A

0.798

0.993

−0.019

0.003

4.6E − 10

 

8

rs1571582

9

103663962

RP11-394D2.1/

RP11-62L10.1

T/C

0.498

0.997

−0.016

0.002

3.4E − 11

 

9

rs201449027

12

9142784

KLRG1/RP11-259O18.4

TG/T

0.561

0.965

0.016

0.002

1.4E − 10

 

10

rs4559781

13

28303803

NPM1P4/GSX1

C/T

0.153

0.994

0.020

0.003

2.1E − 09

 

11

rs139221256

15

85357857

ZNF592/ALPK3

T/TA

0.749

0.991

0.016

0.003

5.8E − 09

 

12

rs12601771

17

4108822

ANKFY1

G/A

0.433

0.995

0.015

0.002

5.6E − 10

 

13

rs8074498a

17

79954544

ASPSCR1

T/A

0.418

0.983

0.016

0.002

1.2E − 10

 

14

rs9610500

22

22221167

MAPK1

A/G

0.634

0.983

−0.015

0.003

4.8E − 09

PC2

15

rs2821226

1

203517292

OPTC/ATP2B4

A/G

0.473

0.984

−0.013

0.002

5.2E − 09

 

16

rs17559978

7

84677860

SEMA3D

G/A

0.688

0.990

0.015

0.002

2.3E − 10

 

17

rs11111069

12

102271962

DRAM1

C/G

0.791

0.995

−0.016

0.003

2.4E − 09

 

18

rs113851179

16

1733479

LA16c-431H6.6/HN1L

C/CT

0.925

0.987

0.026

0.004

8.6E − 10

 

19

rs12979056

19

17862131

FCHO1

G/A

0.542

0.992

−0.014

0.002

1.5E − 09

 

20

rs3788337

22

23412017

RTDR1

G/A

0.647

0.993

−0.014

0.002

6.5E − 09

PC3

21

rs56049037

7

32947201

AVL9

G/A

0.713

0.988

0.016

0.002

1.3E − 11

 

22

8:11053467-GA:G

8

11053467

XKR6

GA/G

0.555

0.914

0.014

0.002

1.6E − 09

 

23

rs11494758

12

9116542

KLRG1

C/T

0.622

0.997

−0.014

0.002

3.4E − 10

 

24

rs71272625

15

78166843

LINGO1/CSPG4P13

C/CT

0.331

0.931

0.014

0.002

8.8E − 10

 

25

rs11373181

22

42705672

TCF20

A/AC

0.482

0.990

−0.013

0.002

3.6E − 10

PC4

26

13:58551593-GA:G

13

58551593

PCDH17/RNA5SP30

GA/G

0.763

0.993

−0.016

0.002

2.4E − 11

PC5

27

rs138572890b

16

50264953

PAPD5

C/CTTTA

0.929

0.968

0.023

0.004

7.7E − 10

 

28

19:59007970-CA:C

19

59007970

SLC27A5

CA/C

0.366

0.948

−0.013

0.002

7.0E − 11

  1. The significance threshold was adjusted for multiple testing across six traits (p < 8.3 × 10−9).
  2. Loc. locus, Chr. chromosome, E/A effect and alternative alleles, EAF effect allele frequency, INFO imputation quality score.
  3. aMissense variant.
  4. b3′ UTR variant.